In December, Walgreens announced its plans to cut more than $1 billion from its annual costs over the next three years in order to stay agile in an increasingly competitive retail space. As Amazon continues to edge into the pharmaceutical space, Walgreens has increased its partnerships and consumer offerings. The drug store completed its nearly $4.4 billion acquisition of more than 1,900 Rite Aid stores and three distribution centers in March, although the stores won’t be fully integrated into Walgreens until the 2020 fiscal year. In the past year, the drugstore has also partnered with Humana to offer senior-focused care, Alphabet’s Verily to assist patients with chronic illness, FedEx to offer next-day prescription delivery, and Kroger to test an in-store grocery pilot and let Walgreens serve as a pickup point for online grocery orders. The drugstore has also cleared space for CBD products to be sold in 1,500 stores across nine states.
Company Info
| CEO | Stefano Pessina |
| CEO Title | Chairman & Chief Executive Officer |
| Sector | Food & Drug Stores |
| Industry | Food and Drug Stores |
| HQ Location | Deerfield, Ill. |
| Website | www.walgreensbootsalliance.com |
| Years on Fortune 500 List | 25 |
| Employees | 299,000 |
Key Financials (Last Fiscal Year)
| Revenues ($M) | $131,537 |
| Profits ($M) | $5,024 |
| Assets ($M) | $68,124 |
| Total Stockholder Equity ($M) | $26,007 |
Profit Ratios
| Profit as % of Revenues | 3.8% |
| Profits as % of Assets | 7.4% |
| Profits as % of Stockholder Equity | 19.3% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 505 |
| EPS % Change (from 2017) | 33.6% |
| EPS % Change (5 year annual rate) | 14.6% |
| EPS % Change (10 year annual rate) | 8.8% |
Total Return
| Total Return to Investors (2018) | -3.7% |
| Total Return to Investors (5 year, annualized) | 5.5% |
| Total Return to Investors (10 year, annualized) | 13.0% |
